Friday, June 21, 2024 2:11:40 PM
Why did the EMA want Novavax to prove their new covid vaccine could show the same results over time, and across a wider area?
In terms of the PREACH-M and RATinG studies, we know that CMML and aGvHD patients may finally have a cure.
Sorry to deduce that lenz may have improved the CAR-T and non-mRNA covid vaccine efficacies, based on speculation, without as much evidence as we see for CMML and aGvHD. I have noted the co-exclusive licensing deal announced between Sanofi and Novavax, for what that might be worth to you, ahead of evidence that lenz is the common denominator, and the licensed product.
There is probably nobody that is more eager for good news than I am, nor more disappointed when potential announcement dates come and go without news.
If people have no clue about what is happening, if they have no appreciation of what lenzilumab's success could mean to them as investors, and they would prefer to be left to wonder, then they should stop reading my posts. Or not. Because as time goes on, I see only MORE reason to be wildly optimistic, as I am. That should come as, "... no news."
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM